Roche launches 2-in-1 biotech drug for breast cancer in India
The two medicines prescribed together is a standard treatment regimen approved in over 100 countries for both early and metastatic HER2-positive breast cancer.
The two medicines prescribed together is a standard treatment regimen approved in over 100 countries for both early and metastatic HER2-positive breast cancer.
